Alexandria Real Estate Equities, Inc.
Case Overview
60 Days Left to Seek Lead Plaintiff
| Lead Plaintiff Deadline: | Lead Plaintiff Deadline: 01/26/2026 |
| Status: | Status: Investigating |
| Company Name: | Company Name: Alexandria Real Estate Equities, Inc. |
| Court: | Court: Central District of California |
| Case Number: | Case Number: 2:25cv11319 |
| Class Period: | Class Period: 01/27/2025 - 10/27/2025 |
| Ticker: | Ticker: ARE |
| Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
| Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Alexandria Real Estate Equities, Inc. (“Alexandria” or the “Company”) (NYSE:ARE) securities during the period of January 27, 2025 through October 27, 2025, inclusive (“the Class Period”).
The lawsuit alleges that the Company did not have “reliable information pertaining to the Company’s leasing spreads, development tenant pipeline, and anticipated occupancy growth for its life-science properties, specifically its Long Island City (“LIC”) property while also minimizing risk from macroeconomic fluctuations.” The lawsuit further argues that “the Company’s LIC value and potential growth as a life-science destination had been declining for years,” consequently making the Company’s optimistic reports about its “development pipeline, high occupancy rates in North America and anticipated leasing growth” materially misleading.
On October 27, 2025, Alexandria reported its Q3 2025 financial results which revealed quarterly earnings that failed to match analyst expectations, declining revenues, a 7% decline in adjusted funds from operations. The release attributed the results to lower occupancy rates, slower leasing activity, and a real estate impairment charge of $323.9 million with $206 million attributed to the LIC property. On this news, the price of Alexandria shares declined by $14.93 per share, or approximately 19.17%, from $77.87 per share on October 27, 2025 to close at $62.94 on October 28, 2025.
The lawsuit alleges that the Company did not have “reliable information pertaining to the Company’s leasing spreads, development tenant pipeline, and anticipated occupancy growth for its life-science properties, specifically its Long Island City (“LIC”) property while also minimizing risk from macroeconomic fluctuations.” The lawsuit further argues that “the Company’s LIC value and potential growth as a life-science destination had been declining for years,” consequently making the Company’s optimistic reports about its “development pipeline, high occupancy rates in North America and anticipated leasing growth” materially misleading.
On October 27, 2025, Alexandria reported its Q3 2025 financial results which revealed quarterly earnings that failed to match analyst expectations, declining revenues, a 7% decline in adjusted funds from operations. The release attributed the results to lower occupancy rates, slower leasing activity, and a real estate impairment charge of $323.9 million with $206 million attributed to the LIC property. On this news, the price of Alexandria shares declined by $14.93 per share, or approximately 19.17%, from $77.87 per share on October 27, 2025 to close at $62.94 on October 28, 2025.